GH1 Splicing Is Regulated by Multiple Enhancers Whose Mutation Produces a Dominant-Negative GH Isoform That Can Be Degraded by Allele-Specific Small Interfering RNA (siRNA)
Authors:
- 1 June 2004
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 145 (6) , 2988-2996
Abstract
The majority of mutations that cause isolated GH deficiency type II affect splicing of GH1 transcripts, leading to the production of a dominant-negative GH isoform. Because numerous mutations and polymorphisms throughout the GH1 gene have not yet been tested for aberrant splicing, we used a deletion mutagenesis screen across intron 2-exon 3-intron 3 to identify splicing regulatory sequences. These analyses identified a new enhancer element, ESE2, upstream of the cryptic splice site in exon 3 and further defined a previously described enhancer (ESE1) to include the first seven nucleotides of exon 3. Besides enhancers, the overall size of intron 3 is also crucial for exon inclusion. Given the deleterious effects of the dominant-negative 17.5-kDa isoform, these and previous studies underscore the extent to which splicing regulatory elements serve to prevent exon skipping. Importantly, we show here that small interfering RNAs can be used to specifically degrade exon 3-skipped transcripts, potentially a new avenue of therapeutic intervention in isolated GH deficiency II and other dominant disorders.Keywords
This publication has 44 references indexed in Scilit:
- Mechanisms of Alternative Pre-Messenger RNA SplicingAnnual Review of Biochemistry, 2003
- Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD IIHuman Genetics, 2003
- Autosomal Dominant Growth Hormone Deficiency Disrupts Secretory Vesiclesin Vitroandin Vivoin Transgenic MiceEndocrinology, 2003
- Pre-mRNA splicing in the new millenniumCurrent Opinion in Cell Biology, 2001
- Alternative pre-mRNA splicing: the logic of combinatorial controlTrends in Biochemical Sciences, 2000
- Autosomal Dominant Growth Hormone (GH) Deficiency Type II: The Del32–71-GH Deletion Mutant Suppresses Secretion of Wild-Type GH1Endocrinology, 2000
- A novel mutation at the donor splice site of intron 3 of the GH-I gene in a patient with isolated growth hormone deficiencyGrowth Hormone & IGF Research, 1999
- The molecular genetics of growth hormone deficiencyHuman Genetics, 1998
- Identification of a New Class of Exonic Splicing Enhancers by In Vivo SelectionMolecular and Cellular Biology, 1997
- Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the ComplexScience, 1992